Source Post
The creator discusses BioVaxys Technology Corp. (BVXF), highlighting its unique DPX delivery platform for i...
Bdon TradesDec 15, 2025
The creator discusses BioVaxys Technology Corp. (BVXF), highlighting its unique DPX delivery platform for immunotherapies. The platform's versatility and long-lasting immune response potential are emphasized, with applications in oncology, RSV, and allergy desensitization. The creator expresses strong interest in the mechanism and its potential to revolutionize immunotherapies.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.